128 related articles for article (PubMed ID: 21325766)
1. Severe hypercalcemia associated with hepatocellular carcinoma secreting intact parathyroid hormone: a case report.
Abe Y; Makiyama H; Fujita Y; Tachibana Y; Kamada G; Uebayashi M
Intern Med; 2011; 50(4):329-33. PubMed ID: 21325766
[TBL] [Abstract][Full Text] [Related]
2. Life-threatening hypercalcemia from a hepatocellular carcinoma secreting intact parathyroid hormone: localization by sestamibi single-photon emission computed tomographic imaging.
Mahoney EJ; Monchik JM; Donatini G; De Lellis R
Endocr Pract; 2006; 12(3):302-6. PubMed ID: 16772205
[TBL] [Abstract][Full Text] [Related]
3. Intact PTH-producing hepatocellular carcinoma treated by transcatheter arterial embolization.
Koyama Y; Ishijima H; Ishibashi A; Katsuya T; Ishizaka H; Aoki J; Endo K
Abdom Imaging; 1999; 24(2):144-6. PubMed ID: 10024399
[TBL] [Abstract][Full Text] [Related]
4. Fatal parathyroid hormone-related protein-induced humoral hypercalcemia of malignancy in a 3-month-old infant.
Lakhdir F; Lawson D; Schatz DA
Eur J Pediatr; 1994 Oct; 153(10):718-20. PubMed ID: 7813527
[TBL] [Abstract][Full Text] [Related]
5. Complete Tumor Resection for a Hepatocellular Carcinoma Secreting Parathyroid Hormone-related Peptide.
Kim EK; Kim JS; Shin KC; Lee GT; Han CJ; Kim SB; Ku YH
Korean J Gastroenterol; 2015 Aug; 66(2):122-6. PubMed ID: 26289247
[TBL] [Abstract][Full Text] [Related]
6. Hypercalcemia and parathyroid hormone-related protein in hepatocellular carcinoma.
Yen TC; Hwang SJ; Wang CC; Lee SD; Yeh SH
Liver; 1993 Dec; 13(6):311-5. PubMed ID: 8295494
[TBL] [Abstract][Full Text] [Related]
7. Transcatheter arterial chemo-embolization for humoral hypercalcemia of hepatocellular carcinoma.
Suzuki K; Kono N; Ono A; Osuga Y; Kiyokawa H; Mineo I; Matsuda Y; Miyoshi S; Kawata S; Minami Y
Gastroenterol Jpn; 1988 Feb; 23(1):29-36. PubMed ID: 2832239
[TBL] [Abstract][Full Text] [Related]
8. Prostaglandin-E-producing hepatocellular carcinoma with hypercalcemia.
Ikeda T; Tozuka S; Hasumura Y; Takeuchi J
Cancer; 1988 May; 61(9):1813-4. PubMed ID: 2833340
[TBL] [Abstract][Full Text] [Related]
9. Severe hypercalcemia as an initial presenting manifestation of hepatocellular carcinoma.
Ghobrial MW; George J; Mannam S; Henien SR
Can J Gastroenterol; 2002 Sep; 16(9):607-9. PubMed ID: 12362213
[TBL] [Abstract][Full Text] [Related]
10. Humoral hypercalcemia associated with gastric carcinoma secreting parathyroid hormone: a case report and review of the literature.
Nakajima K; Tamai M; Okaniwa S; Nakamura Y; Kobayashi M; Niwa T; Horigome N; Ito N; Suzuki S; Nishio S; Komatsu M
Endocr J; 2013; 60(5):557-62. PubMed ID: 23303131
[TBL] [Abstract][Full Text] [Related]
11. Sepsis caused by Anaerococcus nagyae after transarterial-chemoembolization for hepatocellular carcinoma: Case report and literature review.
Toprak NU; Sayin E; Akilli FM; Gundogdu A
Anaerobe; 2021 Dec; 72():102464. PubMed ID: 34597796
[TBL] [Abstract][Full Text] [Related]
12. Tuberculosis reactivation in hepatocellular carcinoma: association with transarterial chemoembolization.
Laake AM; Liappis AP; Guy E; Kerr G; Benator DA
Infect Dis (Lond); 2015 Apr; 47(4):267-70. PubMed ID: 25688446
[TBL] [Abstract][Full Text] [Related]
13. Mixed hepato/cholangiocarcinoma with paraneoplastic hypercalcemia.
Maarouf A; Adham M; Scoazec JY; Partensky C
J Hepatobiliary Pancreat Surg; 2008; 15(2):224-7. PubMed ID: 18392720
[TBL] [Abstract][Full Text] [Related]
14. Small hepatocellular carcinoma associated with Wilson's disease.
Kumagi T; Horiike N; Abe M; Kurose K; Iuchi H; Masumoto T; Joko K; Akbar SF; Michitaka K; Onji M
Intern Med; 2005 May; 44(5):439-43. PubMed ID: 15942090
[TBL] [Abstract][Full Text] [Related]
15. Serial serum VEGF-A, angiopoietin-2, and endostatin measurements in cirrhotic patients with hepatocellular carcinoma treated by transcatheter arterial chemoembolization.
Hsieh MY; Lin ZY; Chuang WL
Kaohsiung J Med Sci; 2011 Aug; 27(8):314-22. PubMed ID: 21802642
[TBL] [Abstract][Full Text] [Related]
16. Hypercalcaemia secondary to hepatocellular carcinoma.
Leone N; Debernardi-Venon W; Marzano A; Massari M; Rizzetto M
Ital J Gastroenterol Hepatol; 1999 Oct; 31(7):604-6. PubMed ID: 10604102
[TBL] [Abstract][Full Text] [Related]
17. [Transarterial chemoembolization (TACE) of the hepatocellular carcinoma (HCC) in patients with portal vein thrombosis--experiences].
Herber S; Pitton M; Mönch C; Schneider J; Manzl N; Kummer I; Kanzler S; Schuchmann M; Junginger T; Düber C; Otto G
Zentralbl Chir; 2007 Aug; 132(4):306-15. PubMed ID: 17724633
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of serum osteopontin in hepatocellular carcinoma patients treated with transarterial chemoembolization.
Kim SH; Chung YH; Yang SH; Kim JA; Jang MK; Kim SE; Lee D; Lee SH; Lee D; Kim KM; Lim YS; Lee HC; Lee YS; Suh DJ
Korean J Hepatol; 2009 Sep; 15(3):320-30. PubMed ID: 19783881
[TBL] [Abstract][Full Text] [Related]
19. Liver failure after transarterial chemoembolization for patients with hepatocellular carcinoma and ascites: incidence, risk factors, and prognostic prediction.
Hsin IF; Hsu CY; Huang HC; Huang YH; Lin HC; Lee RC; Chiang JH; Lee FY; Huo TI; Lee SD
J Clin Gastroenterol; 2011 Jul; 45(6):556-62. PubMed ID: 21666547
[TBL] [Abstract][Full Text] [Related]
20. [A case of infiltrative hepatocellular carcinoma with main portal vein tumor thrombosis successfully treated by transarterial chemoembolization].
Myung SJ; Yoon JH; Gwak GY; Shin CM; Ahn DW; Yu SJ; Yu JW; Cho SJ; Chung JW; Lee HS
Korean J Hepatol; 2006 Mar; 12(1):107-11. PubMed ID: 16565612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
